Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3332091 | Hematology/Oncology Clinics of North America | 2007 | 27 Pages |
Abstract
Bone is an important organ that is essential to adult hematopoiesis, electrolyte balance, and locomotion. Individuals who have metastatic breast cancer involving the bone are at increased risk for skeletal complications and those who have a history of early-stage breast cancer may be at increased risk for fragility fractures. Maintaining bone integrity is critical to control the morbidity and mortality associated with fractures and other skeletal complications. The bisphosphonates have been shown to be efficacious in decreasing the risk for skeletal complications in cancer and in osteoporosis. The article reviews the use of bisphosphonates in patients who have breast cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Rachel Layman, Karin Olson, Catherine Van Poznak,